Published in Mol Cell Biol on August 28, 2006
miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res (2008) 8.97
miRiad roles for the miR-17-92 cluster in development and disease. Cell (2008) 8.02
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol (2008) 4.76
MicroRNAs in cancer. Annu Rev Pathol (2009) 4.47
Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol (2007) 4.16
MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A (2008) 4.06
Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One (2010) 3.50
MiRNAs and cancer. Am J Pathol (2009) 3.42
mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol (2010) 3.15
A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol (2008) 3.02
MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res (2010) 2.83
MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics (2010) 2.80
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One (2011) 2.70
MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol (2009) 2.49
Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res (2009) 2.43
The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci U S A (2009) 2.29
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol (2008) 2.29
Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res (2009) 2.27
Leukaemogenesis: more than mutant genes. Nat Rev Cancer (2010) 2.16
MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol (2011) 2.15
MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res (2011) 2.15
p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol Syst Biol (2008) 2.04
A simple array platform for microRNA analysis and its application in mouse tissues. RNA (2007) 1.91
Roles of small RNAs in tumor formation. Trends Mol Med (2010) 1.89
MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood (2010) 1.88
MicroRNAs in tumorigenesis: a primer. Am J Pathol (2007) 1.83
MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett (2012) 1.73
MicroRNAs, cancer and cancer stem cells. Cancer Lett (2010) 1.65
Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget (2012) 1.65
The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells. Gut (2015) 1.60
Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia (2010) 1.58
microRNA and stem cell function. Cell Tissue Res (2007) 1.54
Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA (2009) 1.48
MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol (2009) 1.45
"Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet (2007) 1.45
Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc Natl Acad Sci U S A (2010) 1.43
microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med (2007) 1.43
Circular reasoning: microRNAs and cell-cycle control. Trends Biochem Sci (2008) 1.41
Expression profile of microRNAs in c-Myc induced mouse mammary tumors. Breast Cancer Res Treat (2008) 1.41
Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res (2010) 1.40
The proto-oncogene LRF is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One (2008) 1.37
ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulation. J Biol Chem (2009) 1.34
Retroviral activation of the mir-106a microRNA cistron in T lymphoma. Retrovirology (2007) 1.33
miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology (2010) 1.32
mir-17-92: a polycistronic oncomir with pleiotropic functions. Immunol Rev (2013) 1.32
microRNA, cell cycle, and human breast cancer. Am J Pathol (2010) 1.32
microRNA and cancer. AAPS J (2010) 1.32
The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer. Breast Cancer Res Treat (2009) 1.29
miRNAs and estrogen action. Trends Endocrinol Metab (2012) 1.24
A high throughput experimental approach to identify miRNA targets in human cells. Nucleic Acids Res (2009) 1.24
Dysregulation of microRNAs in cancer. J Biomed Sci (2012) 1.20
Estrogen Regulation of MicroRNA Expression. Curr Genomics (2009) 1.20
Enjoy the Silence: The Story of let-7 MicroRNA and Cancer. Curr Genomics (2007) 1.19
miRNA Biomarkers in Breast Cancer Detection and Management. J Cancer (2011) 1.18
miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth. Nat Commun (2015) 1.18
The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptor-alpha (ERalpha) signaling and a luminal phenotype in MCF-7 breast cancer cells. Mol Endocrinol (2009) 1.17
The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol (2012) 1.17
MicroRNAs in cancer treatment and prognosis. Am J Cancer Res (2012) 1.17
Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci (2011) 1.12
The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol (2013) 1.12
Regulation of breast cancer and bone metastasis by microRNAs. Dis Markers (2013) 1.12
Friend or foe: the role of microRNA in chemotherapy resistance. Acta Pharmacol Sin (2013) 1.11
MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival. Biol Direct (2011) 1.10
Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis. Curr Genomics (2010) 1.09
Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS One (2013) 1.09
Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs. Genome Biol (2014) 1.08
Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer (2012) 1.07
Nuclear receptor coactivators: structural and functional biochemistry. Biochemistry (2010) 1.06
MicroRNA-182-5p targets a network of genes involved in DNA repair. RNA (2012) 1.06
Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technology. BMC Biotechnol (2008) 1.05
Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int (2009) 1.04
MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression. Pharmaceuticals (Basel) (2013) 1.04
Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci (2013) 1.03
The roles of microRNAs in tumorigenesis and angiogenesis. Int J Physiol Pathophysiol Pharmacol (2010) 1.03
Derailed estrogen signaling and breast cancer: an authentic couple. Endocr Rev (2012) 1.01
Molecular pathways: microRNAs as cancer therapeutics. Clin Cancer Res (2012) 1.01
Up-regulation of miR-210 by vascular endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated angiogenesis. J Cell Mol Med (2012) 1.01
Retracted The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci (2008) 1.00
Identification of novel homologous microRNA genes in the rhesus macaque genome. BMC Genomics (2008) 1.00
microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells. Cancer Biol Ther (2013) 0.98
MicroRNA expression in lymphoid malignancies: new hope for diagnosis and therapy? J Cell Mol Med (2008) 0.97
MicroRNA expression in canine mammary cancer. Mamm Genome (2008) 0.97
MicroRNAs in cancer therapeutic response: Friend and foe. World J Clin Oncol (2014) 0.96
Alterations of ROBO1/DUTT1 and ROBO2 loci in early dysplastic lesions of head and neck: clinical and prognostic implications. Hum Genet (2008) 0.96
miRNAs in breast cancer tumorigenesis (Review). Oncol Rep (2011) 0.96
Minireview: steroid receptor coactivator-3: a multifarious coregulator in mammary gland metastasis. Endocrinology (2010) 0.95
MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives. Genes Dis (2014) 0.94
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94
Small players with big roles: microRNAs as targets to inhibit breast cancer progression. Curr Drug Targets (2010) 0.93
miR-20a and miR-290, multi-faceted players with a role in tumourigenesis and senescence. J Cell Mol Med (2010) 0.93
MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers. Breast Cancer Res (2014) 0.92
Can microRNAs improve the management of lung cancer patients? A clinician's perspective. Theranostics (2013) 0.92
miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1. Oncotarget (2014) 0.92
Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? Front Genet (2012) 0.92
Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs. RNA Biol (2012) 0.91
MicroRNA expressions associated with progression of prostate cancer cells to antiandrogen therapy resistance. Mol Cancer (2014) 0.90
Steroid receptor coactivator-3 as a potential molecular target for cancer therapy. Expert Opin Ther Targets (2012) 0.90
Designing small multiple-target artificial RNAs. Nucleic Acids Res (2010) 0.88
Robustness and backbone motif of a cancer network regulated by miR-17-92 cluster during the G1/S transition. PLoS One (2013) 0.88
Vitamin D3 up-regulated protein 1(VDUP1) is regulated by FOXO3A and miR-17-5p at the transcriptional and post-transcriptional levels, respectively, in senescent fibroblasts. J Biol Chem (2010) 0.87
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
The functions of animal microRNAs. Nature (2004) 64.85
Prediction of mammalian microRNA targets. Cell (2003) 53.70
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
RAS is regulated by the let-7 microRNA family. Cell (2005) 30.24
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
Principles of microRNA-target recognition. PLoS Biol (2005) 23.70
bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell (2003) 22.14
Specificity of microRNA target selection in translational repression. Genes Dev (2004) 21.14
MicroRNA genes are transcribed by RNA polymerase II. EMBO J (2004) 20.65
MicroRNA maturation: stepwise processing and subcellular localization. EMBO J (2002) 19.47
miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev (2002) 19.24
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86
The Microprocessor complex mediates the genesis of microRNAs. Nature (2004) 17.70
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev (2003) 17.64
Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res (2003) 17.13
Nuclear export of microRNA precursors. Science (2003) 16.59
A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 15.02
Processing of primary microRNAs by the Microprocessor complex. Nature (2004) 14.59
Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A (2005) 12.96
MicroRNAs regulate brain morphogenesis in zebrafish. Science (2005) 11.16
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46
A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell (2005) 9.22
Transcription and processing of human microRNA precursors. Mol Cell (2004) 8.98
microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A (2006) 8.24
Single processing center models for human Dicer and bacterial RNase III. Cell (2004) 8.19
AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05
Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res (2004) 7.96
MicroRNAs as oncogenes and tumor suppressors. N Engl J Med (2005) 5.67
MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A (2005) 5.54
Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci U S A (1985) 4.58
High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell (2004) 3.46
Connections and regulation of the human estrogen receptor. Science (2002) 3.26
Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev (1998) 2.50
ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol (2004) 2.46
AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol (2000) 2.18
Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci U S A (2000) 2.17
Ovalbumin messenger RNA of chick oviduct: partial characterization, estrogen dependence, and translation in vitro. Proc Natl Acad Sci U S A (1972) 1.60
Role of the steroid receptor coactivator SRC-3 in cell growth. Mol Cell Biol (2003) 1.53
Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer (2000) 1.43
Profiling microRNA expression using sensitive cDNA probes and filter arrays. Biotechniques (2004) 1.41
Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells. J Biol Chem (2001) 1.38
Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer (1999) 1.37
Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol (1999) 1.36
AIB1 enhances estrogen-dependent induction of cyclin D1 expression. Cancer Res (2001) 1.35
The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res (2004) 1.32
Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer (1998) 1.28
The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells. J Biol Chem (1994) 1.12
High frequency loss of heterozygosity on the long arms of chromosomes 13 and 14 in nasopharyngeal carcinoma in Southern China. Chin Med J (Engl) (2002) 1.05
Functional activity of ectopically expressed estrogen receptor is not sufficient for estrogen-mediated cyclin D1 expression. Cancer Res (1999) 0.96
Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer (1999) 0.95
Molecular dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain development. Development (2004) 1.53
PAX6, paired domain influences sequence recognition by the homeodomain. J Biol Chem (2002) 1.16
Iris hypoplasia in mice that lack the alternatively spliced Pax6(5a) isoform. Proc Natl Acad Sci U S A (2002) 1.08
Missense mutations in the DNA-binding region and termination codon in PAX6. Hum Mutat (2003) 1.08
The BRCA1 3'-UTR: 5711+421T/T_5711+1286T/T genotype is a possible breast and ovarian cancer risk factor. Genet Test Mol Biomarkers (2009) 1.00
Novel PAX6 binding sites in the human genome and the role of repetitive elements in the evolution of gene regulation. Genome Res (2002) 0.96
Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing. Mol Endocrinol (2004) 0.94
Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter. Biol Reprod (2003) 0.93
Functional and structural characterization of the human gene BHLHB5, encoding a basic helix-loop-helix transcription factor. Genomics (2002) 0.93
N-terminally truncated WT1 protein with oncogenic properties overexpressed in leukemia. J Biol Chem (2006) 0.93
A method for isolating alternatively spliced isoforms: isolation of murine Pax6 isoforms. Anal Biochem (2002) 0.91
Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor. J Biol Chem (2003) 0.91
Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer. Hum Mutat (2002) 0.89
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation. Mol Cell Biochem (2012) 0.85
The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells. Mol Cancer Ther (2012) 0.85
Functional analysis of familial Asp67Glu and Thr1051Ser BRCA1 mutations in breast/ovarian carcinogenesis. Int J Mol Sci (2009) 0.76